• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑腱性黄瘤病的最新进展。

Update on cerebrotendinous xanthomatosis.

机构信息

Department of Chemical Physiology & Biochemistry.

Knight Cardiovascular Institute, and Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

Curr Opin Lipidol. 2021 Apr 1;32(2):123-131. doi: 10.1097/MOL.0000000000000740.

DOI:10.1097/MOL.0000000000000740
PMID:33630770
Abstract

PURPOSE OF REVIEW

Cerebrotendinous xanthomatosis (CTX) is a rare genetic lipid storage disorder with highly pleomorphic clinical phenotype. Complications of this disease can be devastating and may include severe cognitive impairment and dementia in later stages. Disease progression can be prevented or stabilized by bile acid replacement therapy, although a subset of patients with advanced disease continue to deteriorate despite therapy.

RECENT FINDINGS

Delayed diagnosis of CTX continues to impede effective treatment. A clinical diagnostic algorithm for CTX was developed that can decrease the age of diagnosis of CTX. The strategy of screening children with bilateral juvenile cataracts for CTX also improved diagnosis, as this group had a 500-fold higher-rate of CTX than the general population. Improved diagnosis of CTX is critical, as patients treated early in the course of the disease have significantly better outcomes compared with those treated later. More sensitive and specific biochemical testing for CTX has been developed that is potentially more informative than blood cholestanol to assess treatment efficacy and medication compliance in CTX.

SUMMARY

Because we are recognizing more severe presentations of CTX in infants and children, and delayed diagnosis and treatment worsens the prognosis, CTX is an excellent candidate disorder for newborn screening using recently reported methods for newborn dried bloodspot analysis.

摘要

目的综述

脑腱黄瘤病(CTX)是一种罕见的遗传性脂质贮积病,具有高度多样的临床表型。该疾病的并发症可能是毁灭性的,包括严重的认知障碍和后期的痴呆。尽管胆汁酸替代疗法可以预防或稳定疾病进展,但仍有一部分晚期疾病患者尽管接受了治疗仍继续恶化。

最新发现

CTX 的延迟诊断继续阻碍有效的治疗。已经开发出一种用于 CTX 的临床诊断算法,可以降低 CTX 的诊断年龄。对双侧青少年白内障儿童进行 CTX 筛查的策略也改善了诊断,因为这一群体的 CTX 发病率比一般人群高 500 倍。改善 CTX 的诊断至关重要,因为在疾病早期治疗的患者与晚期治疗的患者相比,其预后显著改善。已经开发出更敏感和更特异的 CTX 生化检测方法,与血胆甾醇相比,该方法在评估 CTX 的治疗效果和药物依从性方面更具信息性。

总结

由于我们在婴儿和儿童中发现了更严重的 CTX 表现,且延迟诊断和治疗会使预后恶化,因此使用最近报道的新生儿干血斑分析方法进行新生儿筛查,CTX 是一种极好的候选疾病。

相似文献

1
Update on cerebrotendinous xanthomatosis.脑腱性黄瘤病的最新进展。
Curr Opin Lipidol. 2021 Apr 1;32(2):123-131. doi: 10.1097/MOL.0000000000000740.
2
Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts.前瞻性检测青少年起病不明原因双侧白内障患者中的脑腱黄瘤病的胆固醇醇水平。
Orphanet J Rare Dis. 2022 Dec 13;17(1):434. doi: 10.1186/s13023-022-02591-4.
3
Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study.诊治和管理脑腱黄瘤病(CTX)患者的专家意见:一项改良 Delphi 研究。
Orphanet J Rare Dis. 2021 Aug 6;16(1):353. doi: 10.1186/s13023-021-01980-5.
4
Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols.基因和临床确诊的非典型脑腱黄瘤病,伴有正常胆甾烷醇和胆汁酸前体及胆汁醇显著升高。
J Clin Lipidol. 2024 May-Jun;18(3):e465-e476. doi: 10.1016/j.jacl.2024.03.004. Epub 2024 Mar 15.
5
Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.脑腱黄瘤病:发病机制、临床表现、诊断及治疗的全面综述
Orphanet J Rare Dis. 2014 Nov 26;9:179. doi: 10.1186/s13023-014-0179-4.
6
Prevalence of cerebrotendinous xanthomatosis among patients diagnosed with early-onset idiopathic bilateral cataracts: final analysis.早发性特发性双侧白内障患者中脑腱性黄色瘤病的患病率:最终分析。
J AAPOS. 2023 Aug;27(4):208-211. doi: 10.1016/j.jaapos.2023.04.013. Epub 2023 Jun 14.
7
Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.一名患有脑腱性黄瘤病的婴儿补充鹅去氧胆酸后出现肝毒性:对治疗的启示
Eur J Pediatr. 2016 Jan;175(1):143-6. doi: 10.1007/s00431-015-2584-7. Epub 2015 Jul 10.
8
Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts.脑腱性黄瘤病:基于青少年白内障的早期诊断
J AAPOS. 2017 Dec;21(6):505-507. doi: 10.1016/j.jaapos.2017.07.211. Epub 2017 Oct 24.
9
A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns.一种用于脑腱黄瘤病的血液检测方法,具有在新生儿中进行疾病检测的潜力。
J Lipid Res. 2014 Jan;55(1):146-54. doi: 10.1194/jlr.P043273. Epub 2013 Nov 2.
10
A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios.一种利用胆汁醇葡萄糖醛酸苷和代谢物比率筛查脑腱性黄瘤病的新生儿筛查方法。
J Lipid Res. 2017 May;58(5):1002-1007. doi: 10.1194/jlr.P075051. Epub 2017 Mar 17.

引用本文的文献

1
A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia.个性化医疗方法最适合纯合子家族性高胆固醇血症患者。
Med Res Arch. 2024 Dec;12(12). doi: 10.18103/mra.v12i12.6160. Epub 2024 Dec 24.
2
A sterol panel for rare lipid disorders: sitosterolemia, cerebrotendinous xanthomatosis and Smith-Lemli-Opitz syndrome.用于罕见脂质紊乱的固醇检测项目:谷甾醇血症、脑腱黄瘤病和史密斯-莱姆利-奥皮茨综合征。
J Lipid Res. 2025 Jan;66(1):100698. doi: 10.1016/j.jlr.2024.100698. Epub 2024 Nov 19.
3
Frontier and hotspot evolution in cerebrotendinous xanthomatosis: a bibliometric analysis from 1993 to 2023.
脑腱黄瘤病的前沿与热点演变:1993年至2023年的文献计量分析
Front Neurol. 2024 Jul 26;15:1371375. doi: 10.3389/fneur.2024.1371375. eCollection 2024.
4
Cerebrotendinous xanthomatosis with tremor as the main manifestation: A case report.以震颤为主要表现的脑腱黄瘤病:一例报告。
Medicine (Baltimore). 2024 Apr 26;103(17):e37976. doi: 10.1097/MD.0000000000037976.
5
Transitional Medicine of Intractable Primary Dyslipidemias in Japan.日本原发性难治性血脂异常的转化医学。
J Atheroscler Thromb. 2024 May 1;31(5):501-519. doi: 10.5551/jat.RV22016. Epub 2024 Mar 26.
6
Cerebrotendinous Xanthomatosis patients with late diagnosed in single orthopedic clinic: two novel variants in the CYP27A1 gene.单一骨科诊所中诊断较晚的脑腱黄瘤病患者:CYP27A1 基因的两个新变异。
Orphanet J Rare Dis. 2024 Feb 9;19(1):53. doi: 10.1186/s13023-024-03082-4.
7
The 20-Year Diagnostic Odyssey of a Milder Form of Cerebrotendinous Xanthomatosis.一种较轻型脑腱黄瘤病的20年诊断历程
JCEM Case Rep. 2024 Jan 19;2(2):luae004. doi: 10.1210/jcemcr/luae004. eCollection 2024 Feb.
8
Living with Cerebrotendinous Xanthomatosis: Patient, Caregiver, and Expert Perspectives.与脑腱黄瘤病共存:患者、护理人员及专家观点
Adv Ther. 2024 Feb;41(2):467-475. doi: 10.1007/s12325-023-02687-8. Epub 2023 Dec 19.
9
Allelic prevalence and geographic distribution of cerebrotendinous xanthomatosis.脑腱性黄瘤病的等位基因流行率和地理分布。
Orphanet J Rare Dis. 2023 Jan 17;18(1):13. doi: 10.1186/s13023-022-02578-1.
10
Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newborns.新生儿脑腱黄瘤病筛查:20000 例新生儿采用流动注射和 UPLC-MS/MS 分析的回顾性生物标志物研究。
Clin Chim Acta. 2023 Jan 15;539:170-174. doi: 10.1016/j.cca.2022.12.011. Epub 2022 Dec 16.